HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rupert Egensperger Selected Research

Polyneuropathies (Polyneuropathy)

7/2009Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of cisplatin-induced neuropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rupert Egensperger Research Topics

Disease

14Neoplasms (Cancer)
01/2022 - 06/2010
11Glioma (Gliomas)
10/2022 - 02/2011
6Alzheimer Disease (Alzheimer's Disease)
11/2012 - 08/2006
5Glioblastoma (Glioblastoma Multiforme)
03/2023 - 02/2011
2Astrocytoma (Pilocytic Astrocytoma)
10/2022 - 01/2022
2Brain Neoplasms (Brain Tumor)
01/2022 - 11/2016
2Oligodendroglioma
01/2022 - 06/2021
2Amyloid Plaque
11/2012 - 08/2008
1Disease Progression
10/2022
1Meningioma (Meningiomas)
06/2019
1Central Nervous System Vasculitis
11/2018
1Neuroblastoma
09/2012
1Nervous System Diseases (Neurological Disorders)
06/2012
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2012
1Progressive Multifocal Leukoencephalopathy
01/2012
1Peripheral Nervous System Diseases (PNS Diseases)
08/2010
1Hyperalgesia
08/2010
1Hyperplasia
08/2010
1Chordoma
06/2010
1Polyneuropathies (Polyneuropathy)
07/2009

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
11/2018 - 08/2008
4Temozolomide (Temodar)FDA LinkGeneric
10/2022 - 02/2011
4Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
10/2022 - 01/2019
4Biomarkers (Surrogate Marker)IBA
01/2019 - 11/2011
3MethyltransferasesIBA
04/2021 - 02/2011
3Messenger RNA (mRNA)IBA
05/2013 - 02/2011
3Amyloid (Amyloid Fibrils)IBA
11/2012 - 08/2008
2protoporphyrin IXIBA
04/2021 - 04/2013
2AcidsIBA
04/2021 - 04/2013
2Tyrosine (L-Tyrosine)FDA Link
01/2019 - 05/2015
2Iodine-125IBA
11/2016 - 03/2016
2Alkylating AgentsIBA
05/2013 - 02/2011
2Cisplatin (Platino)FDA LinkGeneric
08/2010 - 07/2009
1Photosensitizing Agents (Photosensitizers)IBA
04/2021
1GadoliniumIBA
01/2019
1Tacrolimus (Prograf)FDA LinkGeneric
11/2018
1A-Form DNA (A-DNA)IBA
05/2013
1EnzymesIBA
05/2013
1MicroRNAs (MicroRNA)IBA
05/2013
1(18F)fluoroethyltyrosineIBA
12/2012
1Acetylcholine (Acetylcholine Chloride)FDA Link
11/2012
1S-Adenosylmethionine (Ademetionine)IBA
11/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2012
1ClusterinIBA
09/2012
1fludarabineIBA
01/2012
1Rituximab (Mabthera)FDA Link
01/2012
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2012
12-toluenesulfonamide (OTS)IBA
11/2011
1DNA (Deoxyribonucleic Acid)IBA
02/2011
1ErythropoietinFDA Link
08/2010
1tributyl phosphate (TBP)IBA
06/2010
1Cathepsin DIBA
03/2010
1Macrophage Migration-Inhibitory FactorsIBA
03/2010
1Peptide Hydrolases (Proteases)FDA Link
03/2010
1Amyloid beta-PeptidesIBA
08/2008
1Plasminogen Activators (Plasminogen Activator)IBA
08/2006
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
08/2006

Therapy/Procedure

4Radiotherapy
12/2019 - 02/2011
3Photochemotherapy (Photodynamic Therapy)
03/2023 - 04/2013
3Drug Therapy (Chemotherapy)
10/2022 - 05/2013
3Therapeutics
01/2022 - 06/2019
2Precision Medicine
01/2022 - 01/2022
2Brachytherapy
11/2016 - 03/2016
1Operative Surgical Procedures
01/2022
1Salvage Therapy
11/2016
1Aftercare (After-Treatment)
01/2012